Literature DB >> 33338686

Optimizing omalizumab dosing in severe asthma-the exploration of therapeutic drug monitoring.

Johannes Anthon Kroes1, Sander Wilhelm Zielhuis2, Akke-Nynke van der Meer3, Kim de Jong4, Eric Nico van Roon5, Anneke Ten Brinke3.   

Abstract

Entities:  

Year:  2020        PMID： 33338686     DOI： 10.1016/j.jaip.2020.12.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  2 in total

1.  Evaluation of Real-Life Investigational Use of Enoximone in Asthma, the Third Step in Drug Repurposing: A Preliminary Report.

Authors:  Jan Beute; Pieter Boermans; Alex KleinJan
Journal:  Can Respir J       Date:  2021-11-01       Impact factor: 2.409

2.  Towards precision drug therapy in asthma.

Authors:  Job F M van Boven
Journal:  Ann Transl Med       Date:  2022-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.